There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

CHARLESTOWN, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SLDB) (the “Company”), a life sciences company developing ...

Amavita has started using AISAP’s AI-powered POCUS diagnostic in community settings for aortic stenosis screening.

The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

Researchers have found in a new study that receiving an implantable cardioverter-defibrillator (ICD) within the last six ...

EBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device.

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

"AISAP is proud to collaborate with forward-thinking practices and community partners like Amavita," said Roni Attali, AISAP ...

Due to uncertainty within the data, the impact of looser driving restrictions still merits close scrutiny, a researcher says.